Schedule II Drug Prescribing Would Require CME Under FDA, DEA Proposal
Executive Summary
FDA and the Drug Enforcement Administration are encouraging legislation to require continuing medical education for renewal of DEA registration to prescribe Schedule II drugs
You may also be interested in...
HHS IG To Study EPO, OxyContin Reimbursement In 2004 Reports
The HHS' Inspector General plans to study the "appropriateness" of epoetin alfa Medicare reimbursements for patients who have not been diagnosed with end stage renal disease
HHS IG To Study EPO, OxyContin Reimbursement In 2004 Reports
The HHS' Inspector General plans to study the "appropriateness" of epoetin alfa Medicare reimbursements for patients who have not been diagnosed with end stage renal disease
Palladone Phased Launch Should Collect One Year Of Abuse Data, Cmte. Says
The first phase of launch for Purdue's Palladone (hydromorphone) should collect data on abuse and diversion for a year, FDA's Anesthetic & Life Support Advisory Committee recommended Sept. 10